Drawing for FITELTO

USPTO serial 85009745

FITELTO

Reviewed by CopyMark Law Group

Reg. 4460733Status 710
Filing date
Status date
Registration date
Jan 7, 2014
Examiner
MCMORROW, JANICE LEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with FITELTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

Christopher M. Hanes GlaxoSmithKlineFive Moore DriveLegal Global Trademarks, Mailstop: 5.5AResearch Triangle Park, NC 27709-0183

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccinesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2020C8..CANCELLED SEC. 8 (6-YR)—
Jan 7, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 23, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 27, 2013DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Nov 18, 2013IUCNNOTICE OF ALLOWANCE CANCELLED—
Nov 18, 2013D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Jun 8, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 7, 2013EX5GSOU EXTENSION 5 GRANTED—
May 29, 2013EXT5SOU EXTENSION 5 FILED—
May 29, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 20, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 20, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 15, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 30, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2012EX4GSOU EXTENSION 4 GRANTED—
Nov 28, 2012EXT4SOU EXTENSION 4 FILED—
Nov 28, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 5, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 4, 2012EX3GSOU EXTENSION 3 GRANTED—
May 25, 2012EXT3SOU EXTENSION 3 FILED—
May 25, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 19, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2011EX2GSOU EXTENSION 2 GRANTED—
Nov 16, 2011EXT2SOU EXTENSION 2 FILED—
Nov 16, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 14, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2011EX1GSOU EXTENSION 1 GRANTED—
Jun 10, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 7, 2011EXT1SOU EXTENSION 1 FILED—
Jun 7, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 12, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 12, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 9, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 9, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2010ALIEASSIGNED TO LIE—
Aug 20, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 14, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2010DOCKASSIGNED TO EXAMINER—
May 13, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 13, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 12, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance